Fierce Pharma October 11, 2024
Nick Paul Taylor

A survey of more than 2,000 patients and physicians has painted a rosy picture of the impact of pharma ads, showing that promotions raise awareness of treatment options, drive discovery of health conditions and improve management of existing ailments.

The survey is the result of a collaboration between media intelligence business Magna and advertising platform DeepIntent. Together, the businesses ran online surveys of 1,166 patients and 1,001 doctors to determine whether pharma ads do more than just build brands. Advocates of direct-to-consumer ads argue they have educational value and improve health. The survey gathered data to support that view.

First, Magna and DeepIntent showed pharma ads do their primary job: raising awareness of treatments. Almost two-thirds of patients said they...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Physician, Provider, Survey / Study, Trends
‘He needs to do much more’: RFK Jr.'s measles response under scrutiny
How this ASC eliminated patient falls
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Trump: Administration will ‘keep our children healthy and strong’
The 'dark matter' of nutrition: How AI and network science are transforming our understanding of food and health

Share This Article